Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pan-cancer analysis and experimental validation reveal FAM72D as a potential novel biomarker and therapeutic target in lung adenocarcinoma.

Gene - 30 Nov 2024

Zhou Zonglang, Fan Bingfu, Qiu Qinming, Cheng Hongrong, Wang Li, Wu Yibo, Xie Jun, Ni Cheng, Li Ning

Abstract excerpt

BACKGROUND: Cancers, particularly lung adenocarcinoma (LUAD), represent a major global health concern. However, the role of FAM72D in various cancers, including LUAD, remains poorly understood. METHODS: We utilized databases such as The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression Project (GTEx) and online tools to investigate the correlation between FAM72D expression and its prognostic, diagnostic, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Apoptosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Cell Line, Tumor

Share to Cell Proliferation

Share to Gene Expression Regulation, Neoplastic

Share to Lung Neoplasms

Share to Prognosis

Source

Identifiers

PMID: 39013484
DOI: 10.1016/j.gene.2024.148764

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pan-cancer analysis and experimental validation reveal FAM72D as a potential novel biomarker and therapeutic target in lung adenocarcinoma.PMID 39013484Read ↗

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinomaSemantic proximity Read ↗

FAM83A: A Prospective Diagnostic Biomarker with Immunological Relevance in Lung Adenocarcinoma- Associated Malignant Pleural EffusionSemantic proximity Read ↗

The pan-cancer analysis reveals FAM72D as a potential therapeutic target and closely linked to immune infiltration and prognosis in hepatocellular carcinomaSemantic proximity Read ↗

Unraveling the Expression Patterns of Immune Checkpoints Identifies New Subtypes and Emerging Therapeutic Indicators in Lung AdenocarcinomaSemantic proximity Read ↗

Integrative single-cell analysis of LUAD: elucidating immune cell dynamics and prognostic modeling based on exhausted CD8+ T cellsSemantic proximity Read ↗

Prognostic and immunological implications of paraptosis‐related genes in lung adenocarcinoma: Comprehensive analysis and functional verification of hub geneSemantic proximity Read ↗

FAM83A Is a Prognosis Signature and Potential Oncogene of Lung AdenocarcinomaSemantic proximity Read ↗

Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype.Semantic proximity Read ↗

Multi-omics analysis of core E3 ubiquitin ligase identifies prognostic biomarkers associated with immune infiltration and drug sensitivity in lung adenocarcinomaSemantic proximity Read ↗

Tumor microenvironment and drug resistance in lung adenocarcinoma: molecular mechanisms, prognostic implications, and therapeutic strategiesSemantic proximity Read ↗

Integrated single-cell and bulk RNA-Seq analysis enhances prognostic accuracy of PD-1/PD-L1 immunotherapy response in lung adenocarcinoma through necroptotic anoikis gene signaturesSemantic proximity Read ↗

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.